{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:51:59Z","timestamp":1772164319803,"version":"3.50.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"13","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ovarian cancer is the most lethal gynecologic malignancy, often diagnosed at advanced stage leading to poor prognosis. In the study reported here, magnetic resonance imaging and near-infrared reflectance imaging were applied for in vivo analysis of two competing endocytic pathways affecting retention of bifunctional daidzein-bovine serum albumin (BSA)\u2013based contrast media by human epithelial ovarian carcinoma cells. Suppression of caveolae-mediated uptake using nystatin or by BSA competition significantly enhanced daidzein-BSA-GdDTPA\/CyTE777 uptake by tumor cells in vitro. In vivo, perivascular myofibroblasts generated an effective perivascular barrier excluding delivery of BSA-GdDTPA\/CyTE777 to tumor cells. The ability to manipulate caveolae-mediated sequestration of albumin by perivascular tumor myofibroblasts allowed us to effectively overcome this tumor-stroma barrier, increasing delivery of daidzein-BSA-GdDTPA\/CyTE777 to the tumor cells in tumor xenografts. Thus, both in vitro and in vivo, endocytosis of daidzein-BSA-GdDTPA\/CyTE777 by ovarian carcinoma cells was augmented by albumin or by nystatin. In view of the cardinal role of albumin in affecting the availability and pharmacokinetics of drugs, this approach could potentially also facilitate the delivery of therapeutics and contrast media to tumor cells. [Cancer Res 2009;69(13):5610\u20137]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4967","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T01:34:36Z","timestamp":1244597676000},"page":"5610-5617","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Harnessing Competing Endocytic Pathways for Overcoming the Tumor-Blood Barrier: Magnetic Resonance Imaging and Near-Infrared Imaging of Bifunctional Contrast Media"],"prefix":"10.1158","volume":"69","author":[{"given":"Helena Sheikhet","family":"Migalovich","sequence":"first","affiliation":[{"name":"1Biological Regulation and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyacheslav","family":"Kalchenko","sequence":"additional","affiliation":[{"name":"2Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nava","family":"Nevo","sequence":"additional","affiliation":[{"name":"1Biological Regulation and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gila","family":"Meir","sequence":"additional","affiliation":[{"name":"1Biological Regulation and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortune","family":"Kohen","sequence":"additional","affiliation":[{"name":"1Biological Regulation and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Neeman","sequence":"additional","affiliation":[{"name":"1Biological Regulation and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"2022061701481950900_B1","doi-asserted-by":"crossref","unstructured":"Lazennec G. Estrogen receptor \u03b2, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett\u20082006; 231: 151\u20137.","DOI":"10.1016\/j.canlet.2005.01.021"},{"key":"2022061701481950900_B2","doi-asserted-by":"crossref","unstructured":"Schiffenbauer YS, Meir G, Maoz M, Even-Ram SC, Bar-Shavit R, Neeman M. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by \u03b1 (v)-integrin. Gynecol Oncol\u20082002; 84: 296\u2013302.","DOI":"10.1006\/gyno.2001.6512"},{"key":"2022061701481950900_B3","doi-asserted-by":"crossref","unstructured":"Gilead A, Meir G, Neeman M. The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids. Int J Cancer\u20082004; 108: 524\u201331.","DOI":"10.1002\/ijc.11583"},{"key":"2022061701481950900_B4","doi-asserted-by":"crossref","unstructured":"Neeman M, Dafni H, Bukhari O, Braun RD, Dewhirst MW. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med\u20082001; 45: 887\u201398.","DOI":"10.1002\/mrm.1118"},{"key":"2022061701481950900_B5","doi-asserted-by":"crossref","unstructured":"Gilad AA, Israely T, Dafni H, Meir G, Cohen B, Neeman M. Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: the role of stroma cells in tumor angiogenesis. Int J Cancer\u20082005; 117: 202\u201311.","DOI":"10.1002\/ijc.21179"},{"key":"2022061701481950900_B6","doi-asserted-by":"crossref","unstructured":"Dafni H, Landsman L, Schechter B, Kohen F, Neeman M. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed\u20082002; 15: 120\u201331.","DOI":"10.1002\/nbm.724"},{"key":"2022061701481950900_B7","doi-asserted-by":"crossref","unstructured":"Israely T, Nevo N, Harmelin A, Neeman M, Tsafriri A. Reducing ischaemic damage in rodent ovarian xenografts transplanted into granulation tissue. Hum Reprod\u20082006; 21: 1368\u201379.","DOI":"10.1093\/humrep\/del010"},{"key":"2022061701481950900_B8","doi-asserted-by":"crossref","unstructured":"Plaks V, Kalchenko V, Dekel N, Neeman M. MRI analysis of angiogenesis during mouse embryo implantation. Magn Reson Med\u20082006; 55: 1013\u201322.","DOI":"10.1002\/mrm.20881"},{"key":"2022061701481950900_B9","doi-asserted-by":"crossref","unstructured":"Granot D, Kunz-Schughart LA, Neeman M. Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging. Magn Reson Med\u20082005; 54: 789\u201397.","DOI":"10.1002\/mrm.20628"},{"key":"2022061701481950900_B10","doi-asserted-by":"crossref","unstructured":"Granot D, Addadi Y, Kalchenko V, Harmelin A, Kunz-Schughart LA, Neeman M. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Res\u20082007; 67: 9180\u20139.","DOI":"10.1158\/0008-5472.CAN-07-0684"},{"key":"2022061701481950900_B11","doi-asserted-by":"crossref","unstructured":"Stuart ES, Webley WC, Norkin LC. Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells. Exp Cell Res\u20082003; 287: 67\u201378.","DOI":"10.1016\/S0014-4827(03)00059-4"},{"key":"2022061701481950900_B12","doi-asserted-by":"crossref","unstructured":"Geninatti Crich S, Barge A, Battistini E, et al. Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates. J Biol Inorg Chem\u20082005; 10: 78\u201386.","DOI":"10.1007\/s00775-004-0616-2"},{"key":"2022061701481950900_B13","doi-asserted-by":"crossref","unstructured":"Somjen D, Katzburg S, Nevo N, et al. A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma. J Steroid Biochem Mol Biol\u20082008; 110: 144\u20139.","DOI":"10.1016\/j.jsbmb.2008.03.033"},{"key":"2022061701481950900_B14","doi-asserted-by":"crossref","unstructured":"Harris DM, Besselink E, Henning SM, Go VL, Heber D. Phytoestrogens induce differential estrogen receptor \u03b1- or \u03b2-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood)\u20082005; 230: 558\u201368.","DOI":"10.1177\/153537020523000807"},{"key":"2022061701481950900_B15","doi-asserted-by":"crossref","unstructured":"Kohen F, Gayer B, Kulik T, et al. Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine. J Med Chem\u20082007; 50: 6405\u201310.","DOI":"10.1021\/jm070727z"},{"key":"2022061701481950900_B16","doi-asserted-by":"crossref","unstructured":"Geninatti Crich S, Cabella C, Barge A, et al. In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes. J Med Chem\u20082006; 49: 4926\u201336.","DOI":"10.1021\/jm0601093"},{"key":"2022061701481950900_B17","doi-asserted-by":"crossref","unstructured":"Sun C, Sze R, Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A\u20082006; 78: 550\u20137.","DOI":"10.1002\/jbm.a.30781"},{"key":"2022061701481950900_B18","unstructured":"Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2\/neu receptor. Cancer Res\u20082003; 63: 2723\u20137."},{"key":"2022061701481950900_B19","doi-asserted-by":"crossref","unstructured":"Dafni H, Gilead A, Nevo N, Eilam R, Harmelin A, Neeman M. Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin. Magn Reson Med\u20082003; 50: 904\u201314.","DOI":"10.1002\/mrm.10638"},{"key":"2022061701481950900_B20","doi-asserted-by":"crossref","unstructured":"Hilderbrand SA, Kelly KA, Weissleder R, Tung CH. Monofunctional near-infrared fluorochromes for imaging applications. Bioconjug Chem\u20082005; 16: 1275\u201381.","DOI":"10.1021\/bc0501799"},{"key":"2022061701481950900_B21","doi-asserted-by":"crossref","unstructured":"Bhattacharya A, Seshadri M, Oven SD, Toth K, Vaughan MM, Rustum YM. Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs. Clin Cancer Res\u20082008; 14: 3926\u201332.","DOI":"10.1158\/1078-0432.CCR-08-0212"},{"key":"2022061701481950900_B22","doi-asserted-by":"crossref","unstructured":"Bouzin C, Feron O. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist Updat\u20082007; 10: 109\u201320.","DOI":"10.1016\/j.drup.2007.03.001"},{"key":"2022061701481950900_B23","doi-asserted-by":"crossref","unstructured":"Somjen D, Stern N, Knoll E, et al. Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells. J Endocrinol\u20082003; 179: 395\u2013403.","DOI":"10.1677\/joe.0.1790395"},{"key":"2022061701481950900_B24","doi-asserted-by":"crossref","unstructured":"Lehtonen JY, Adlercreutz H, Kinnunen PK. Binding of daidzein to liposomes. Biochim Biophys Acta\u20081996; 1285: 91\u2013100.","DOI":"10.1016\/S0005-2736(96)00154-X"},{"key":"2022061701481950900_B25","doi-asserted-by":"crossref","unstructured":"Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol\u20082006; 246: 91\u2013100.","DOI":"10.1016\/j.mce.2005.11.020"},{"key":"2022061701481950900_B26","doi-asserted-by":"crossref","unstructured":"Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1\/2 signaling pathway in colon and breast cancer cells. J Endocrinol\u20082005; 185: 577\u201392.","DOI":"10.1677\/joe.1.05770"},{"key":"2022061701481950900_B27","doi-asserted-by":"crossref","unstructured":"Heberden C, Reine F, Grosse B, et al. Detection of a raft-located estrogen receptor-like protein distinct from ER \u03b1. Int J Biochem Cell Biol\u20082006; 38: 376\u201391.","DOI":"10.1016\/j.biocel.2005.09.006"},{"key":"2022061701481950900_B28","doi-asserted-by":"crossref","unstructured":"Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol\u20082005; 39: 5143\u20136.","DOI":"10.1097\/01.mcg.0000155514.17715.39"},{"key":"2022061701481950900_B29","doi-asserted-by":"crossref","unstructured":"Sharma R, Hook J, Kumar M, Gabra H. Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer\u20082008; 44: 251\u20136.","DOI":"10.1016\/j.ejca.2007.11.011"},{"key":"2022061701481950900_B30","unstructured":"Atkins MB, Robertson MJ, Gordon M, et al. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res\u20081997; 3: 409\u201317."},{"key":"2022061701481950900_B31","doi-asserted-by":"crossref","unstructured":"Frankel AE, Zuckero SL, Mankin AA, et al. Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma. Curr Drug Targets\u20082009; 10: 104\u20139.","DOI":"10.2174\/138945009787354539"},{"key":"2022061701481950900_B32","doi-asserted-by":"crossref","unstructured":"Hochhauser D, Meyer T, Spanswick VJ, et al. Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors. Clin Cancer Res\u20082009; 15: 2140\u20137.","DOI":"10.1158\/1078-0432.CCR-08-1315"},{"key":"2022061701481950900_B33","unstructured":"Ohnuma T, Holland JF, Freeman A, Sinks LF. Biochemical and pharmacological studies with asparaginase in man. Cancer Res\u20081970; 30: 2297\u2013305."},{"key":"2022061701481950900_B34","doi-asserted-by":"crossref","unstructured":"Bagley RG, Weber W, Rouleau C, Teicher BA. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res\u20082005; 65: 9741\u201350.","DOI":"10.1158\/0008-5472.CAN-04-4337"},{"key":"2022061701481950900_B35","doi-asserted-by":"crossref","unstructured":"Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell\u20082005; 121: 335\u201348.","DOI":"10.1016\/j.cell.2005.02.034"},{"key":"2022061701481950900_B36","unstructured":"Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res\u20082002; 8: 2912\u201323."},{"key":"2022061701481950900_B37","unstructured":"McAlhany SJ, Ressler SJ, Larsen M, et al. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res\u20082003; 63: 5859\u201365."},{"key":"2022061701481950900_B38","doi-asserted-by":"crossref","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer\u20082006; 6: 392\u2013401.","DOI":"10.1038\/nrc1877"},{"key":"2022061701481950900_B39","doi-asserted-by":"crossref","unstructured":"Sund M, Kalluri R. Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev\u20082009; 28: 177\u201383.","DOI":"10.1007\/s10555-008-9175-2"},{"key":"2022061701481950900_B40","doi-asserted-by":"crossref","unstructured":"Bergamaschi A, Tagliabue E, Sorlie T, et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol\u20082008; 214: 357\u201367.","DOI":"10.1002\/path.2278"},{"key":"2022061701481950900_B41","doi-asserted-by":"crossref","unstructured":"McIntosh DP, Tan XY, Oh P, Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A\u20082002; 99: 1996\u20132001.","DOI":"10.1073\/pnas.251662398"},{"key":"2022061701481950900_B42","doi-asserted-by":"crossref","unstructured":"Carver LA, Schnitzer JE. Caveolae: mining little caves for new cancer targets. Nat Rev Cancer\u20082003; 3: 571\u201381.","DOI":"10.1038\/nrc1146"},{"key":"2022061701481950900_B43","doi-asserted-by":"crossref","unstructured":"Teneriello MG, Tseng PC, Crozier M, et al. Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. J Clin Oncol\u20082009; 27: 1426\u201331.","DOI":"10.1200\/JCO.2008.18.9548"},{"key":"2022061701481950900_B44","doi-asserted-by":"crossref","unstructured":"Desai N, Trieu V, Yao Z, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res\u20082006; 12: 1317\u201324.","DOI":"10.1158\/1078-0432.CCR-05-1634"},{"key":"2022061701481950900_B45","doi-asserted-by":"crossref","unstructured":"Perez EA. Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer. Breast Cancer Res Treat\u20082009; 114: 195\u2013201.","DOI":"10.1007\/s10549-008-0005-6"},{"key":"2022061701481950900_B46","doi-asserted-by":"crossref","unstructured":"Karmali PP, Kotamraju VR, Kastantin M, et al. Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine\u20082009; 5: 73\u201382.","DOI":"10.1016\/j.nano.2008.07.007"},{"key":"2022061701481950900_B47","doi-asserted-by":"crossref","unstructured":"Kurahashi N, Iwasaki M, Inoue M, Sasazuki S, Tsugane S. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. J Clin Oncol\u20082008; 26: 5923\u20139.","DOI":"10.1200\/JCO.2008.16.8807"},{"key":"2022061701481950900_B48","doi-asserted-by":"crossref","unstructured":"Singh-Gupta VZH, Banerjee S, Kong D, Raffoul JJ, Sarkar FH, Hillman GG. Radiation-induced HIF-1\u03b1 cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer\u20082009; 124: 1675\u201384.","DOI":"10.1002\/ijc.24015"},{"key":"2022061701481950900_B49","doi-asserted-by":"crossref","unstructured":"Guha N, Kwan ML, Quesenberry CP, Jr., Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. In press 2009.","DOI":"10.1007\/s10549-009-0321-5"},{"key":"2022061701481950900_B50","unstructured":"Eto I. \u201cNutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells.\u201d Cancer Cell Int\u20082006; 6: 20."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/13\/5610\/2612884\/5610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/13\/5610\/2612884\/5610.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:02:15Z","timestamp":1655442135000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/13\/5610\/549828\/Harnessing-Competing-Endocytic-Pathways-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2009,7,1]]},"published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4967","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22379462.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379462","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499259","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499259.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}